Siemens Healthineers: Profit forecast falls due to customs charges!

Siemens Healthineers: Profit forecast falls due to customs charges!

The future of Siemens Healthineers is currently under a questionable star. On November 5, 2025, the company announced that no significant growth is expected for the 2025/26 financial year. As the kma online reported, trade tariffs and negative currency effects are cited as the main reasons for the uncertain forecast.

The financial impact should not be underestimated. Tariffs are expected to burden earnings by around 400 million euros - twice as much as in the previous year. Analysts, however, expected an increase in adjusted earnings per share to 2.48 euros. Instead, the new forecast was reduced to 2.20 to 2.40 euros, which surprised market observers. In the previous year, earnings per share were 2.39 euros and rose by seven percent.

Sales development and challenges

A comparable sales increase of five to six percent is forecast for the current financial year, excluding the stagnating laboratory diagnostics division. Siemens Healthineers was able to increase sales by 5.9 percent to 23.4 billion euros last year, driven by strong demand for imaging technologies and the cancer specialist Varian. In the second quarter of the fiscal year, the company performed better than expected, with sales of 5.9 billion euros and adjusted earnings before interest and taxes (EBIT) increasing by almost 20 percent to 982 million euros. Net profit even increased by a quarter to 537 million euros n-tv reported.

Despite these positive developments, CEO Bernd Montag emphasizes that geopolitical volatility, particularly in trade between the USA and China, poses major challenges for the company. To ease the pressure from tariffs, Siemens Healthineers plans to offset the impact through price increases and savings, and even move some production to the US.

Dividend and investor day

The increase in the dividend to 1 euro per share, which is five cents more than in the previous year, should be mentioned positively. Montag described the past financial year as successful, despite the challenging environment. There will be an investor day on November 17th at which the new medium-term targets will be presented in order to inform shareholders about the future strategy.

Overall, it is clear that, despite a stable basis and solid growth drivers, Siemens Healthineers is facing serious difficulties that the company will have to overcome in the coming months. A good hand in strategic planning could be crucial to staying ahead in the highly competitive market.